Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
No Data
MAIA Biotechnology Q1 EPS $(0.14) Beats $(0.18) Estimate
MAIA Biotechnology | 10-Q: Q1 2026 Earnings Report
MAIA Expands THIO-101 Lung Cancer Trial in U.S.
MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer
MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial
Express News | Maia Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy